reports
- Adrian Kowollik
UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and ...
UPDATE - InvestmentPitch Media Video Discusses Pascal Biosciences and its Non-Brokered Private Placement to Raise up to $900,000 with $0.10 Units – Video Available on Investmentpitch.com VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious diseases, has announced a non-brokered private placement. The company is looking to raise gross proceeds of up to $900,000 from the placement of up to 9 million units priced at $0.10 per unit, with each unit consisting of...
InvestmentPitch Media Video Discusses Pascal Biosciences and its Award...
InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program – Video Available on Investmentpitch.com VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pascal Biosciences (TSXV:PAS) (OTCPink:PSCBF) (FSE:6PB), a biotechnology company targeting innovative therapies for serious diseases, including COVID-19, has been awarded a grant from the National Cancer Institute of the US National Institutes of Health. This two-year grant of US$343,750 will fund development of Pascal's antibody drug f...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.